Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model
- 1 August 2003
- Vol. 24 (8) , 1099-1107
- https://doi.org/10.1016/j.peptides.2003.07.001
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Structure and Mechanism of Action of an Indolicidin Peptide Derivative with Improved Activity against Gram-positive BacteriaJournal of Biological Chemistry, 2001
- The role of cationic antimicrobial peptides in innate host defencesTrends in Microbiology, 2000
- Peptide AntibioticsAntimicrobial Agents and Chemotherapy, 1999
- Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft modelJournal of Clinical Investigation, 1999
- UTP inhibits Na+ absorption in wild-type and ΔF508 CFTR-expressing human bronchial epitheliaAmerican Journal of Physiology-Cell Physiology, 1999
- The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surfaceProceedings of the National Academy of Sciences, 1998
- Interruption of T‐cell signal transduction by lentivirus lytic peptides from HIV‐1 transmembrane proteinChemical Biology & Drug Design, 1998
- A Synthetic Peptide Corresponding to the Carboxy Terminus of Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein Induces Alterations in the Ionic Permeability ofXenopus laevisOocytesAIDS Research and Human Retroviruses, 1997
- MUC1 and Other Sialoglycoconjugates Inhibit Adenovirus-mediated Gene Transfer to Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic FibrosisCell, 1997